This study aimed at: (1) exploring the effects and mechanism of DRP1 inhibitor Mdivi-1 in three clinical cell models of AKI; and (2) examining the specific role of SIRT3 in the AKI models used in this study. Here, DNM1L is linked to acute kidney injury.